Publication: Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Nomak, G.
Oksuzoglu, B.
Senturk, R.
Eralp, Y.
Nomak, H.
Sanyal, R.
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Citation
item.page.haspartof
Source
Annals of Oncology
item.page.ispartofseries
item.page.edition
DOI
10.1016/j.annonc.2022.07.1876
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
